cancer diagnostics

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

Oncology

Solving the ovarian cancer diagnostic and treatment pathway ...

Oncology

pharmaphorum podcast Episode 238, Andrew Newland, ANGLE

Aligning with national efforts to modernise cancer diagnosti...

Andrew Newland, former CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.

Digital

AI in cancer diagnostics and devices: Where we are, and wher...

While it’s only relatively recently that AI became a household term, the technology is already having a major impact on society.

Oncology

Why progress on ovarian cancer treatments is slow

We hear the safety instructions every time we fly – secure your own oxygen mask before assisting your children. This advice serves as a powerful metaphor for women's health.

Oncology

Henar Hevia and Carolyn Sousa at ASCO 2024

ASCO 2024 - Henar Hevia and Carolyn Sousa

The future of cancer care is personalisation. New breakthroughs are increasingly highly targeted, with powerful results, but only for patients with particular genetic markers.

Getting predictive technologies to patients, with Concr

Solving the ovarian cancer diagnostic and treatment pathway ...

Aligning with national efforts to modernise cancer diagnosti...

AI in cancer diagnostics and devices: Where we are, and wher...

Why progress on ovarian cancer treatments is slow

ASCO 2024 - Henar Hevia and Carolyn Sousa

RNAi biotech City hauls in $200m in upsized IPO

Discover a new era of healthcare panel engagement: Grounded ...

cancer diagnostics

Editor's Picks